Navidea Biopharmaceuticals Participates in Symposium Focused on Sentinel Lymph Node Biopsy at the International Symposium on Metastasis in Head and Neck Cancer Feb 5, 2013
Navidea to Collaborate with Maimonides Medical Center on Clinical Trial Utilizing Lymphoseek® for Lymphatic Mapping in Colorectal Cancer Feb 4, 2013
Navidea Biopharmaceuticals Announces Completion of Additional Fundamental Clinical Trial for Radiopharmaceutical Agent, NAV4694, in Alzheimer’s Disease Jan 15, 2013
Navidea Biopharmaceuticals Reaches Interim Analysis Point of Phase 3 Head and Neck Cancer Study of Lymphoseek® Jan 3, 2013
Navidea Biopharmaceuticals Announces Presentation at the 2013 Biotech Showcase™ Conference Jan 2, 2013
Navidea Biopharmaceuticals Submits Lymphoseek Marketing Authorization Application to European Medicines Agency Dec 18, 2012
Navidea Biopharmaceuticals Announces the Presentation of Lymphoseek® Data at Upcoming Scientific Meetings Nov 26, 2012
Navidea Biopharmaceuticals Announces PDUFA Goal Date for Lymphoseek® New Drug Application Resubmission Nov 13, 2012
